Instead, the model simulations highlight the periportal zonation of oxidative phosphorylation and β-oxidation enzymes, along with the pericentral expression of lipogenesis enzymes as the key differences leading to a raised FFA concentration in pericentral cells when simulating insulin resistant NAFLD patients. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.